Although no long - term studies have assessed side effects with low physiologic
doses of growth hormone supplementation in somatopause, the studies we reviewed above have confirmed that low
doses, titrated to keep IGF - 1 levels in the upper limit of
normal, are safe, well tolerated, and associated with a plethora of clinical benefits.